RxDoctor Payments DataLook up a doctor →

Erann Bulman

Gerontology · Knoxville, TNNPI 1841980869

Payments from drug & device makers

$12,742in general payments, 2019–2025

Across 511 payments — averaging $24.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • Lilly USA, LLC$807
  • AstraZeneca$795
  • Johnson & Johnson$600
  • AbbVie$591
  • Pfizer$588
  • plus $7K from 52 others

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis59$2,065
Lilly USA, LLC23$807
AstraZeneca(2 entities)30$795
Johnson & Johnson20$600
AbbVie29$591
Pfizer29$588
E.r. Squibb & Sons, L.L.C.23$566
Bristol Myers Squibb33$508
Merck20$499
Genentech USA, Inc.24$482
Regeneron Healthcare Solutions, Inc.15$400
Gilead(2 entities)9$340
Astellas Pharma US Inc14$276
Takeda Pharmaceuticals U.S.A., Inc.11$270
Bayer13$269
Incyte Corporation11$267
GSK12$262
Eisai Inc.12$236
Daiichi Sankyo Inc.9$222
Sanofi9$222
Iovance Biotherapeutics, Inc.2$160
AVEO Pharmaceuticals, Inc.4$157
Karyopharm Therapeutics Inc.5$150
Puma Biotechnology, Inc.9$149
Deciphera Pharmaceuticals Inc.6$148
Genmab U.S., Inc.7$144
Array Biopharma Inc6$130
Exelixis Inc.4$96
Boehringer Ingelheim4$84
Jazz Pharmaceuticals Inc.3$83
Amgen5$76
Beigene USA, Inc.3$75
EMD Serono, Inc.4$74
Sobi, Inc4$74
ADC Therapeutics America, Inc.3$70
Beone Medicines USA, Inc.3$69
Novocure Inc.4$68
Morphosys, US Inc.3$50
Mirati Therapeutics, Inc.2$50
Blueprint Medicines Corporation2$50
Geron Corporation2$49
Taiho Oncology, Inc.2$43
Pharmacosmos Therapeutics Inc.2$41
Rigel Pharmaceuticals, Inc.2$38
Janssen Scientific Affairs, LLC1$35
Caris MPI, Inc.1$33
Myriad Genetic Laboratories, Inc.2$32
Immunogen, Inc.1$29
Syndax Pharmaceuticals, Inc.1$27
Pharmacyclics LLC, An Abbvie Company1$26
Servier Pharmaceuticals LLC1$25
Pharmaessentia USA Corporation1$24
Springworks Therapeutics, Inc.1$24
G1 Therapeutics, Inc.1$22
Tersera Therapeutics LLC1$21
Apellis Pharmaceuticals, Inc.1$20
Verity Pharmaceuticals Inc.1$19
Ipsen Biopharmaceuticals, Inc1$13

How this compares

$12,742 in reported general payments places this provider in the 95th percentile of 194 gerontology providers in Tennessee.

See all gerontology providers in Tennessee →

Medicare billing

Part B allowed, 2024
$18,734
Medicare patients
61
Services billed
645

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gerontology in Knoxville

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →